Profile
Charles Ruban worked as Vice President-Product Development at Stallergenes SA from 2003 to 2012.
He then worked as Senior EVP-Clinical Development at DBV Technologies SA from 2015 to 2016.
Ruban holds an MBA from INSEAD and an undergraduate degree from Ecole Centrale Lyon.
Former positions of Charles Ruban
| Companies | Position | End |
|---|---|---|
| DBV TECHNOLOGIES | Chief Operating Officer | 2019-03-14 |
| STALLERGENES | Chief Tech/Sci/R&D Officer | 2010-08-03 |
Training of Charles Ruban
| INSEAD | Masters Business Admin |
| Ecole Centrale Lyon | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| DBV TECHNOLOGIES | Health Technology |
| Private companies | 1 |
|---|---|
Stallergenes SA
 Stallergenes SA Pharmaceuticals: MajorHealth Technology Stallergenes SA is an international biopharmaceutical company, which engages in the manufacture and sale of pharmaceutical products for the treatment of allergy-related respiratory diseases. The company operates through the Allergen Immunotherapy segment, which provides products and services for the desensitization of allergy-related respiratory conditions. Its products include a range of sublingual route and subcutaneous route products for the treatment of respiratory diseases such as rhino-conjunctivitis, rhinitis, and allergic asthma. Stallergenes was founded in 1962 and is headquartered in Antony, France. | Health Technology |
- Stock Market
- Insiders
- Charles Ruban
